Eso-SPONGE™
The Eso-SPONGE™ is designed for the prevention and treatment of anastomotic leakages, and for the treatment of perforations, in the upper gastrointestinal tract*, by means of negative pressure including intraluminal or intracavitary therapy of paraoesophageal and mediastinal septic focus or localised abscesses endoscopically accessible.
Key Resources
TREATMENT
How Eso-SPONGE Endoluminal Vacuum Therapy Works
Eso-SPONGE EVT Key steps
A. Position the overtube inside the cavity leaving some space for the sponge to deploy, then place the sponge drain inside the pusher and introduce the hydrogel-impregnated sponge through the overtube.
B. Push the Eso-SPONGE to the mark with the pusher. The sponge is now at the end of the overtube (uncut sponge).
C. Keep pushing and Allow the sponge to expand in the leakage cavity. Use an endoscope to verify its position and adjust if necessary (only the bottom of the sponge must be visible), with endoscopic grasping forceps.
D. Use a CH16 nasogastric tube to place the drain in a transnasal position and then disconnect the gastric tube.
Product Features and Advantages
- The mean treatment duration time reported is less than 30 days. 1, 5, 7-8, 10-12, 14-17, 19-21
- Early treatment is likely to achieve faster healing, shorter duration of treatment & hospital stay and less
complications. 1, 5-8, 10 - Promotes debridement, quick cleaning of the wound cavity.1-11, 13, 15, 17
EVT Clinical Evidence
- The average rate of successful treatment with Eso-SPONGE has been reported to occur in 84% of patients. 1, 5-13
- Likely to be superior to stent treatment and reduced need for surgical revision, and with less strictures 6, 8-9, 14
- Contributes significantly to the reduction of morbidity and mortality of the patients 5-11, 13, 20
- Promotes of granulation tissue ingrowth1-11, 13, 15-17, 19-21
- If necessary, Eso-SPONGE™ can be combined with stent placement or operative revision for better control of the septic focus.1, 5-11, 13, 15,18, 20
PREVENTION OF ANASTOMOTIC LEAKAGES IN THE UPPER GI TRACT
Some patients have higher risk of developing an anastomotic leakage after esophagectomy due existing conditions such as:
- Calcification or arteries 22
- Heart failure, hypertension, renal insufficiency 23
- Obesity 24
- Diabetes 23
Prevalence
- 12.3 % - 13.6 % leakage rate in Cervical anastomosis 23,25
- 2.9 % - 9.3 % leakage rate in Thoracic anastomosis 23,25
Preventive use of Eso-SPONGE
- Follow the insertion system as described for the treatment placing the end of the overtube passed the anastomosis site.
- Release the Eso-SPONGE, and pulled the drainage to position it at the anastomosis site.
- The drainage can be positioned transnasally.
- Connect the device to the recommended vacuum source.
- Apply a continuous negative pressure of 75 mmHg as previously described.
- Leave the sponge for 4 to 6 days and retire the sponge.
Ordering Information
ART.-NO. | NAME | DIAMETER OVERTUBE | CONTENT |
---|---|---|---|
5526550 | Eso-SPONGE | 13 mm Inner: 13 mm Outer: 17 mm | 1 intervention set |
5526540 | Eso-SPONGE | 15 mm Inner: 15 mm Outer: 19 mm | 1 intervention set |
Vacuum source (MV1, MTG Sulzbach)
ART.-NO. | NAME | CONTENT |
---|---|---|
MTG19116 | MV1 | 1x Low vacuum pump |
MTG18022 | Bacterial filter | 20 units |
MTG18032 | Collecting bottle | 15 units |
The Eso-SPONGE Kit includes:
- Overtube (2 sizes available)
- Pusher
- Irrigation set
- Y-shaped connector
- Slide clamp